Lineage extends cash runway into Q2 2028 while advancing OpRegen and new pipeline programs (NYSE:LCTX)

Earnings Call InsightsLineage extends cash runway into Q2 2028 while advancing OpRegen and new pipeline programsMar. 05, 2026 9:46 PM ETLineage Cell Therapeutics, Inc. (LCTX) StockAI-Generated Earnings Calls InsightsCommentsEarnings Call Insights: Lineage Cell Therapeutics (LCTX) Q4 2025 Management View CEO Brian Culley opened the call highlighting recent warrant exercises that have further extended the company's cash runway and announced a positive result for the initial go/no-go development milestoneNewsl ...